Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening.

Massimo Colombo1

  • 1A.M. & A. Migliavacca Center for Liver Disease, Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
|September 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special Populations: Hepatocellular Carcinoma Risk and Liver Transplantation.

Clinics in liver disease·2026
Same author

Insights from Modulation-Excitation Spectroscopy into the Role of Pt Geometrical Sites in the WGS Reaction.

ACS applied materials & interfaces·2025
Same author

DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.

Journal of viral hepatitis·2025
Same author

The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia.

Journal of thrombosis and haemostasis : JTH·2024
Same author

An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.

Nature communications·2024
Same author

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination.

International journal of molecular sciences·2023
Same journal

Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Response to the Letter Regarding "Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis".

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Hepatitis B Virus Infection Status in Japanese Children Prior to Universal Vaccination: Sustained Effectiveness of Mother-to-Child Transmission Prevention and Residual Infection Burden.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative-Intent Local Treatment for Recurrent Hepatocellular Carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Comment on "The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy".

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same journal

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
See all related articles

Regular screening for hepatocellular carcinoma (HCC) in cirrhotic patients significantly improves survival rates by enabling earlier detection and treatment. This study demonstrates a marked decrease in HCC patient mortality over time with consistent surveillance.

Area of Science:

  • Hepatology
  • Oncology
  • Medical Screening

Background:

  • Hepatocellular carcinoma (HCC) management relies on early detection for curative treatments.
  • International guidelines recommend biannual surveillance for high-risk chronic liver disease patients, but survival benefits remain debated due to data limitations.

Purpose of the Study:

  • To evaluate the impact of long-term hepatocellular carcinoma (HCC) surveillance on patient survival in a cohort with compensated cirrhosis.
  • To analyze trends in tumor characteristics and mortality rates over consecutive surveillance periods.

Main Methods:

  • A cohort of 447 Italian patients with compensated cirrhosis underwent regular surveillance.
  • Hepatocellular carcinoma (HCC) development and patient survival were tracked over three consecutive five-year periods.

Related Experiment Videos

  • Tumor size, treatment radicality, and mortality rates were analyzed across the quinquennia.

    • Main Results:

    • Hepatocellular carcinoma (HCC) developed in 112 patients (3.4% per year), becoming the primary cause of death.
    • Mean tumor size decreased significantly over the surveillance periods (3.7 cm to 2.2 cm).
    • Mortality rates among HCC patients dropped substantially from 45% in the first quinquennium to 10% in the third (P = 0.0009).

    Conclusions:

    • Long-term surveillance for hepatocellular carcinoma (HCC) in cirrhotic patients is associated with improved survival.
    • Earlier detection leads to smaller tumors, increased radical therapy application, and reduced mortality.
    • While cost-effectiveness remains debated, surveillance demonstrably enhances patient outcomes.